Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Holtappels, R; Thomas, D; Podlech, J; Reddehase, MJ
   Two antigenic peptides from genes m123 and m164 of murine cytomegalovirus quantitatively dominate CD8 T-cell memory in the H-2(d) haplotype
   JOURNAL OF VIROLOGY
   
   R. Holtappels et al., "Two antigenic peptides from genes m123 and m164 of murine cytomegalovirus quantitatively dominate CD8 T-cell memory in the H-2(d) haplotype", J VIROLOGY, 76(1), 2002, pp. 151-164
2. Willeke, F; Sturm, JW
   Minimal residual disease in soft-tissue sarcomas
   SEMINARS IN SURGICAL ONCOLOGY
   
   F. Willeke e J.W. Sturm, "Minimal residual disease in soft-tissue sarcomas", SEM SURG ON, 20(4), 2001, pp. 294-303
3. Nicolai, T
   Pediatric bronchoscopy
   PEDIATRIC PULMONOLOGY
   
   T. Nicolai, "Pediatric bronchoscopy", PEDIAT PULM, 31(2), 2001, pp. 150-164
4. Kok, LP
   Boon's disease: Hemorrhagic cystitis in conjunction with massive exfoliation of degenerated urothelial cells (apoptosis?) during intercontinental flights in an otherwise healthy person
   DIAGNOSTIC CYTOPATHOLOGY
   
   L.P. Kok, "Boon's disease: Hemorrhagic cystitis in conjunction with massive exfoliation of degenerated urothelial cells (apoptosis?) during intercontinental flights in an otherwise healthy person", DIAGN CYTOP, 25(6), 2001, pp. 361-364
5. Walther, LE; Sens, A; Ebhardt, H; Gudziol, H
   Acute and fulminant fungal sinusitis in immunosuppressed patients.
   LARYNGO-RHINO-OTOLOGIE
   
   L.E. Walther et al., "Acute and fulminant fungal sinusitis in immunosuppressed patients.", LARY RH OTO, 80(7), 2001, pp. 394-399
6. Ino, K; Ageitos, AG; Singh, RK; Talmadge, JE
   Activation-induced T cell apoptosis by monocytes from stem cell products
   INTERNATIONAL IMMUNOPHARMACOLOGY
   
   K. Ino et al., "Activation-induced T cell apoptosis by monocytes from stem cell products", INT IMMUNO, 1(7), 2001, pp. 1307-1319
7. Bruserud, O
   Effects of azoles on human acute myelogenous leukemia blasts and T lymphocytes derived from acute leukemia patients with chemotherapy-induced cytopenia
   INTERNATIONAL IMMUNOPHARMACOLOGY
   
   O. Bruserud, "Effects of azoles on human acute myelogenous leukemia blasts and T lymphocytes derived from acute leukemia patients with chemotherapy-induced cytopenia", INT IMMUNO, 1(12), 2001, pp. 2183-2195
8. Huitema, ADR; Mathot, RAA; Tibben, MM; Rodenhuis, S; Beijnen, JH
   A mechanism-based pharmacokinetic model for the cytochrome P450 drug-drug interaction between cyclophosphamide and thioTEPA and the autoinduction of cyclophosphamide
   JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
   
   A.D.R. Huitema et al., "A mechanism-based pharmacokinetic model for the cytochrome P450 drug-drug interaction between cyclophosphamide and thioTEPA and the autoinduction of cyclophosphamide", J PHARMA PH, 28(3), 2001, pp. 211-230
9. Kessels, HWHG; Wolkers, MC; van den Boom, MD; van der Valk, MA; Schumacher, TNM
   Immunotherapy through TCR gene transfer
   NATURE IMMUNOLOGY
   
   H.W.H.G. Kessels et al., "Immunotherapy through TCR gene transfer", NAT IMMUNOL, 2(10), 2001, pp. 957-961
10. Alyea, EP; Anderson, KC
    Allotransplantation for multiple myeloma
    CANCER JOURNAL
    
    E.P. Alyea e K.C. Anderson, "Allotransplantation for multiple myeloma", CANCER J, 7(3), 2001, pp. 166-174
11. Druker, BJ
    Current treatment approaches for chronic myelogenous leukemia
    CANCER JOURNAL
    
    B.J. Druker, "Current treatment approaches for chronic myelogenous leukemia", CANCER J, 7, 2001, pp. S14-S18
12. Anderson, KC
    Novel biologically based therapies for myeloma
    CANCER JOURNAL
    
    K.C. Anderson, "Novel biologically based therapies for myeloma", CANCER J, 7, 2001, pp. S19-S23
13. Psyrri, A; Murren, J
    Small cell lung cancer: Strategies to optimize chemotherapy response
    CANCER JOURNAL
    
    A. Psyrri e J. Murren, "Small cell lung cancer: Strategies to optimize chemotherapy response", CANCER J, 7, 2001, pp. S28-S34
14. Rajvanshi, P; McDonald, GB
    Expanding the use of transjugular intrahepatic portosystemic shunts for veno-occlusive disease
    LIVER TRANSPLANTATION
    
    P. Rajvanshi e G.B. McDonald, "Expanding the use of transjugular intrahepatic portosystemic shunts for veno-occlusive disease", LIVER TRANS, 7(2), 2001, pp. 154-157
15. Singh, N
    Cytomegalovirus infection of liver transplant recipients: Comparison of antigenemia and molecular biology assays
    LIVER TRANSPLANTATION
    
    N. Singh, "Cytomegalovirus infection of liver transplant recipients: Comparison of antigenemia and molecular biology assays", LIVER TRANS, 7(11), 2001, pp. 1004-1007
16. Fisher, MD
    Update of the French studies of autologous transplantation in multiple myeloma
    CLINICAL LYMPHOMA
    
    M.D. Fisher, "Update of the French studies of autologous transplantation in multiple myeloma", CLIN LYMPHO, 2(2), 2001, pp. 80-83
17. Fisher, MD
    Recombinant immunotoxins in the treatment of Hodgkin's lymphoma
    CLINICAL LYMPHOMA
    
    M.D. Fisher, "Recombinant immunotoxins in the treatment of Hodgkin's lymphoma", CLIN LYMPHO, 2(2), 2001, pp. 84-85
18. Kyle, RA
    Management of patients with multiple myeloma: Emphasizing the role of high-dose therapy
    CLINICAL LYMPHOMA
    
    R.A. Kyle, "Management of patients with multiple myeloma: Emphasizing the role of high-dose therapy", CLIN LYMPHO, 2(1), 2001, pp. 21-28
19. Chiorean, EG; Miller, JS
    The biology of natural killer cells and implications for therapy of human disease
    JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    
    E.G. Chiorean e J.S. Miller, "The biology of natural killer cells and implications for therapy of human disease", J HEMATH ST, 10(4), 2001, pp. 451-463
20. Porter, DL
    The graft-versus-tumor potential of allogeneic cell therapy: an update on donor leukocyte infusions and nonmyeloablative allogeneic stem cell transplantation
    JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    
    D.L. Porter, "The graft-versus-tumor potential of allogeneic cell therapy: an update on donor leukocyte infusions and nonmyeloablative allogeneic stem cell transplantation", J HEMATH ST, 10(4), 2001, pp. 465-480
21. Marijt, WAF; Falkenburg, JHF
    Specific T cell therapy in leukemia
    JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    
    W.A.F. Marijt e J.H.F. Falkenburg, "Specific T cell therapy in leukemia", J HEMATH ST, 10(4), 2001, pp. 493-500
22. Clausen, J; Petzer, AL; Vergeiner, B; Enk, M; Stauder, R; Gastl, G; Gunsilius, E
    Optimal timing for the collection and in vitro expansion of cytotoxic CD56(+) lymphocytes from patients undergoing autologous peripheral blood stem cell transplantation
    JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    
    J. Clausen et al., "Optimal timing for the collection and in vitro expansion of cytotoxic CD56(+) lymphocytes from patients undergoing autologous peripheral blood stem cell transplantation", J HEMATH ST, 10(4), 2001, pp. 513-521
23. Nagler, A; Menachem, Y; Ilan, Y
    Amelioration of steroid-resistant chronic graft-versus-host-mediated liverdisease via tacrolimus treatment
    JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    
    A. Nagler et al., "Amelioration of steroid-resistant chronic graft-versus-host-mediated liverdisease via tacrolimus treatment", J HEMATH ST, 10(3), 2001, pp. 411-417
24. Fehse, B; Chukhlovin, A; Kuhlcke, K; Marinetz, O; Vorwig, O; Renges, H; Kruger, W; Zabelina, T; Dudina, O; Finckenstein, FG; Kroger, N; Kabisch, H; Hochhaus, A; Zander, AR
    Real-time quantitative y chromosome-specific PCR (QYCS-PCR) for monitoringhematopoietic chimerism after sex-mismatched allogeneic stem cell transplantation
    JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    
    B. Fehse et al., "Real-time quantitative y chromosome-specific PCR (QYCS-PCR) for monitoringhematopoietic chimerism after sex-mismatched allogeneic stem cell transplantation", J HEMATH ST, 10(3), 2001, pp. 419-425
25. Godder, KT; Henslee-Downey, PJ
    Colony-stimulating factors in stem cell transplantation: Effect on qualityof life
    JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    
    K.T. Godder e P.J. Henslee-Downey, "Colony-stimulating factors in stem cell transplantation: Effect on qualityof life", J HEMATH ST, 10(2), 2001, pp. 215-228
26. Meehan, KR; Wu, AG; Hassan, R; Miao, YH; Chawla, J; Slack, R; Gehan, E; Herscowitz, HB
    Ex vivo cytokine activation of peripheral blood stem cells: A potential role for adoptive cellular immunotherapy
    JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    
    K.R. Meehan et al., "Ex vivo cytokine activation of peripheral blood stem cells: A potential role for adoptive cellular immunotherapy", J HEMATH ST, 10(2), 2001, pp. 283-290
27. Lau, FY; Wong, R; Chui, CH; Cheng, G
    Successful engraftment in two adult patients with severe aplastic anemia using nonmyeloablative conditioning followed by unrelated HLA-mismatched cord blood transplantation
    JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    
    F.Y. Lau et al., "Successful engraftment in two adult patients with severe aplastic anemia using nonmyeloablative conditioning followed by unrelated HLA-mismatched cord blood transplantation", J HEMATH ST, 10(2), 2001, pp. 309-311
28. Borbolla, JR; Najera, A; Arana, RM; Lopez-Hernandez, MA; Mendoza, Y; Trueba, E
    In vivo purging of peripheral blood stem cells obtained by apheresis, using high-dose chemotherapy and granulocyte colony-stimulating factor in chronic myelogenous leukemia patients
    JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    
    J.R. Borbolla et al., "In vivo purging of peripheral blood stem cells obtained by apheresis, using high-dose chemotherapy and granulocyte colony-stimulating factor in chronic myelogenous leukemia patients", J HEMATH ST, 10(1), 2001, pp. 19-21
29. Gokmen, E; Bachier, C; Raaphorst, FM; Muller, T; Armstrong, D; Lemaistre, CF; Teale, JM
    Ex vivo-expanded hematopoietic cell graft recipients exhibit T cell repertoire diversity similar to that seen after conventional stem cell transplants
    JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    
    E. Gokmen et al., "Ex vivo-expanded hematopoietic cell graft recipients exhibit T cell repertoire diversity similar to that seen after conventional stem cell transplants", J HEMATH ST, 10(1), 2001, pp. 53-66
30. Uyl-de Groot, CA; Hartog, JGD; Huijgens, PC; Willemze, R; Van Ineveld, BM
    Costs of diagnosis, treatment, and follow up of patients with acute myeloid leukemia in the Netherlands
    JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    
    C.A. Uyl-de Groot et al., "Costs of diagnosis, treatment, and follow up of patients with acute myeloid leukemia in the Netherlands", J HEMATH ST, 10(1), 2001, pp. 187-192
31. Kamata, Y; Okuyama, T; Kosuga, M; O'hira, A; Kanaji, A; Sasaki, K; Yamada, M; Azuma, N
    Adenovirus-mediated gene therapy for corneal clouding in mice with mucopolysaccharidosis type VII
    MOLECULAR THERAPY
    
    Y. Kamata et al., "Adenovirus-mediated gene therapy for corneal clouding in mice with mucopolysaccharidosis type VII", MOL THER, 4(4), 2001, pp. 307-312
32. Richard, E; Mendez, M; Mazurier, F; Morel, C; Costet, P; Xia, P; Fontanellas, A; Geronimi, F; Cario-Andre, M; Taine, L; Ged, C; Malik, P; de Verneuil, H; Moreau-Gaudry, F
    Gene therapy of a mouse model of protoporphyria with a self-inactivating erythroid-specific lentiviral vector without preselection
    MOLECULAR THERAPY
    
    E. Richard et al., "Gene therapy of a mouse model of protoporphyria with a self-inactivating erythroid-specific lentiviral vector without preselection", MOL THER, 4(4), 2001, pp. 331-338
33. Chalmers, D; Ferrand, C; Apperley, JF; Melo, JV; Ebeling, S; Newton, I; Duperrier, A; Hagenbeek, A; Garrett, E; Tiberghien, P; Garin, M
    Elimination of the truncated message from the herpes simplex virus thymidine kinase suicide gene
    MOLECULAR THERAPY
    
    D. Chalmers et al., "Elimination of the truncated message from the herpes simplex virus thymidine kinase suicide gene", MOL THER, 4(2), 2001, pp. 146-148
34. Mendoza, GJA; Seidel, NE; Otsu, M; Anderson, SM; Simon-Stoos, K; Herrera, A; Hoogstraten-Miller, S; Malech, HL; Candotti, F; Puck, JM; Bodine, DM
    Comparison of five retrovirus vectors containing the human IL-2 receptor gamma chain gene for their ability to restore T and B lymphocytes in the X-linked severe combined immunodeficiency mouse model
    MOLECULAR THERAPY
    
    G.J.A. Mendoza et al., "Comparison of five retrovirus vectors containing the human IL-2 receptor gamma chain gene for their ability to restore T and B lymphocytes in the X-linked severe combined immunodeficiency mouse model", MOL THER, 3(4), 2001, pp. 565-573
35. Frisella, WA; O'Connor, LH; Vogler, CA; Roberts, M; Walkley, S; Levy, B; Daly, TM; Sands, MS
    Intracranial injection of recombinant adeno-associated virus improves cognitive function in a murine model of mucopolysaccharidosis type VII
    MOLECULAR THERAPY
    
    W.A. Frisella et al., "Intracranial injection of recombinant adeno-associated virus improves cognitive function in a murine model of mucopolysaccharidosis type VII", MOL THER, 3(3), 2001, pp. 351-358
36. Mazurier, F; Geronimi, F; Lamrissi-Garcia, I; Morel, C; Richard, E; Ged, C; Fontanellas, A; Moreau-Gaudry, F; Morey, M; de Verneuil, H
    Correction of deficient CD34(+) cells from peripheral blood after mobilization in a patient with congenital erythropoietic porphyria
    MOLECULAR THERAPY
    
    F. Mazurier et al., "Correction of deficient CD34(+) cells from peripheral blood after mobilization in a patient with congenital erythropoietic porphyria", MOL THER, 3(3), 2001, pp. 411-417
37. Noll, M; Bateman, RL; D'Andrea, AD; Grompe, M
    Preclinical protocol for in vivo selection of hematopoietic stem cells corrected by gene therapy in Fanconi anemia group C
    MOLECULAR THERAPY
    
    M. Noll et al., "Preclinical protocol for in vivo selection of hematopoietic stem cells corrected by gene therapy in Fanconi anemia group C", MOL THER, 3(1), 2001, pp. 14-23
38. Sawai, N; Zhou, S; Vanin, EF; Houghton, P; Brent, TP; Sorrentino, BP
    Protection and in vivo selection of hematopoietic stem cells using temozolomide, O-6-benzylguanine, and an alkyltransferase-expressing retroviral vector
    MOLECULAR THERAPY
    
    N. Sawai et al., "Protection and in vivo selection of hematopoietic stem cells using temozolomide, O-6-benzylguanine, and an alkyltransferase-expressing retroviral vector", MOL THER, 3(1), 2001, pp. 78-87
39. Musk, P; Szmania, S; Galloway, A; Johnson, K; Scott, A; Guttman, S; Bridges, K; Bruorton, M; Gatlin, J; Garcia, JV; Lamb, L; Chiang, KY; Spencer, T; Henslee-Downey, J; van Rhee, F
    In vitro generation of Epstein-Barr virus-specific cytotoxic T cells in patients receiving haplo-identical allogeneic stem cell transplantation
    JOURNAL OF IMMUNOTHERAPY
    
    P. Musk et al., "In vitro generation of Epstein-Barr virus-specific cytotoxic T cells in patients receiving haplo-identical allogeneic stem cell transplantation", J IMMUNOTH, 24(4), 2001, pp. 312-322
40. Foncuberta, MC; Cagnoni, PJ; Brandts, CH; Mandanas, R; Fields, K; Derigs, HG; Reed, E; Sonis, ST; Fay, J; LeVeque, F; Pouillart, P; Schrezenmeier, H; Emmons, R; Thiel, E
    Topical transforming growth factor-beta 3 in the prevention or alleviationof chemotherapy-induced oral mucositis in patients with lymphomas or solidtumors
    JOURNAL OF IMMUNOTHERAPY
    
    M.C. Foncuberta et al., "Topical transforming growth factor-beta 3 in the prevention or alleviationof chemotherapy-induced oral mucositis in patients with lymphomas or solidtumors", J IMMUNOTH, 24(4), 2001, pp. 384-388
41. Sykes, M
    Graft-versus-host alloresponses to treat nonlymphohematopoietic tumors: Isthere a solid approach?
    JOURNAL OF IMMUNOTHERAPY
    
    M. Sykes, "Graft-versus-host alloresponses to treat nonlymphohematopoietic tumors: Isthere a solid approach?", J IMMUNOTH, 24(2), 2001, pp. 101-103
42. Morecki, S; Yacovlev, E; Gelfand, Y; Uzi, I; Slavin, S
    Cell therapy with preimmunized effector cells mismatched for minor histocompatible antigens in the treatment of a murine mammary carcinoma
    JOURNAL OF IMMUNOTHERAPY
    
    S. Morecki et al., "Cell therapy with preimmunized effector cells mismatched for minor histocompatible antigens in the treatment of a murine mammary carcinoma", J IMMUNOTH, 24(2), 2001, pp. 114-121
43. Reed, W; Walters, M; Trachtenberg, E; Smith, R; Lubin, BH
    Sibling donor cord blood banking for children with sickle cell disease
    PEDIATRIC PATHOLOGY & MOLECULAR MEDICINE
    
    W. Reed et al., "Sibling donor cord blood banking for children with sickle cell disease", PEDIAT PATH, 20(2), 2001, pp. 167-174
44. Mankad, VN
    Exciting new treatment approaches for pathophysiologic mechanisms of sickle cell disease
    PEDIATRIC PATHOLOGY & MOLECULAR MEDICINE
    
    V.N. Mankad, "Exciting new treatment approaches for pathophysiologic mechanisms of sickle cell disease", PEDIAT PATH, 20(1), 2001, pp. 1-13
45. Fixler, J; Vichinsky, E; Walters, MC
    Stem cell transplantation for sickle cell disease: Can we reduce the toxicity?
    PEDIATRIC PATHOLOGY & MOLECULAR MEDICINE
    
    J. Fixler et al., "Stem cell transplantation for sickle cell disease: Can we reduce the toxicity?", PEDIAT PATH, 20(1), 2001, pp. 73-86
46. Bacon, PA; Carruthers, D
    New therapeutic aspects: haemopoietic stem cell transplantation
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
    
    P.A. Bacon e D. Carruthers, "New therapeutic aspects: haemopoietic stem cell transplantation", BEST PR R C, 15(2), 2001, pp. 299-313
47. Grimwade, D
    The clinical significance of cytogenetic abnormalities in acute myeloid leukaemia
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    
    D. Grimwade, "The clinical significance of cytogenetic abnormalities in acute myeloid leukaemia", BEST P R C, 14(3), 2001, pp. 497-529
48. Chase, A; Huntly, BJP; Cross, NCP
    Cytogenetics of chronic myeloid leukaemia
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    
    A. Chase et al., "Cytogenetics of chronic myeloid leukaemia", BEST P R C, 14(3), 2001, pp. 553-571
49. Taylor, AMR
    Chromosome instability syndromes
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    
    A.M.R. Taylor, "Chromosome instability syndromes", BEST P R C, 14(3), 2001, pp. 631-644
50. Lowenberg, B
    Prognostic factors in acute myeloid leukaemia
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    
    B. Lowenberg, "Prognostic factors in acute myeloid leukaemia", BEST P R C, 14(1), 2001, pp. 65-75
51. Langmuir, PB; Aplenc, R; Lange, BJ
    Acute myeloid leukaemia in children
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    
    P.B. Langmuir et al., "Acute myeloid leukaemia in children", BEST P R C, 14(1), 2001, pp. 77-93
52. Burnett, AK
    Treatment of acute myeloid leukaemia in younger patients
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    
    A.K. Burnett, "Treatment of acute myeloid leukaemia in younger patients", BEST P R C, 14(1), 2001, pp. 95-118
53. Dann, EJ; Rowe, JM
    Biology and therapy of secondary leukaemias
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    
    E.J. Dann e J.M. Rowe, "Biology and therapy of secondary leukaemias", BEST P R C, 14(1), 2001, pp. 119-137
54. Torelli, GF; Orsini, E; Guarini, A; Kell, J; Foa, R
    Developmental approaches in immunological control of acute myelogenous leukaemia
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    
    G.F. Torelli et al., "Developmental approaches in immunological control of acute myelogenous leukaemia", BEST P R C, 14(1), 2001, pp. 189-209
55. Mieli-Vergani, G; Vergani, D
    Sclerosing cholangitis in the paediatric patient
    BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
    
    G. Mieli-Vergani e D. Vergani, "Sclerosing cholangitis in the paediatric patient", BEST PR RES, 15(4), 2001, pp. 681-690
56. Duplantier, JE; Seyama, K; Day, NK; Hitchcock, R; Nelson, RP; Ochs, HD; Haraguchi, S; Klemperer, MR; Good, RA
    Immunologic reconstitution following bone marrow transplantation for X-linked hyper IgM syndrome
    CLINICAL IMMUNOLOGY
    
    J.E. Duplantier et al., "Immunologic reconstitution following bone marrow transplantation for X-linked hyper IgM syndrome", CLIN IMMUNO, 98(3), 2001, pp. 313-318
57. Stahl, D; Yeshurun, M; Gorin, NC; Sibrowski, W; Kaveri, SV; Kazatchkine, MD
    Reconstitution of self-reactive antibody repertoires of autologous plasma IgM in patients with non-Hodgkin's lymphoma following myeloablative therapy
    CLINICAL IMMUNOLOGY
    
    D. Stahl et al., "Reconstitution of self-reactive antibody repertoires of autologous plasma IgM in patients with non-Hodgkin's lymphoma following myeloablative therapy", CLIN IMMUNO, 98(1), 2001, pp. 31-38
58. Hong, R; Shen, V; Rooney, C; Hughes, DPM; Smith, C; Comoli, P; Zhang, LQ
    Correction of DiGeorge anomaly with EBV-induced lymphoma by transplantation of organ-cultured thymus and Epstein-Barr-specific cytotoxic T lymphocytes
    CLINICAL IMMUNOLOGY
    
    R. Hong et al., "Correction of DiGeorge anomaly with EBV-induced lymphoma by transplantation of organ-cultured thymus and Epstein-Barr-specific cytotoxic T lymphocytes", CLIN IMMUNO, 98(1), 2001, pp. 54-61
59. Nordoy, T; Kolstad, A; Tuck, MK; Aaberge, IS; Husebekk, A; Kaminski, MS
    Radioimmunotherapy with iodine-131 tositumomab in patients with low-grade non-Hodgkin's B-cell lymphoma does not induce loss of acquired humoral immunity against common antigens
    CLINICAL IMMUNOLOGY
    
    T. Nordoy et al., "Radioimmunotherapy with iodine-131 tositumomab in patients with low-grade non-Hodgkin's B-cell lymphoma does not induce loss of acquired humoral immunity against common antigens", CLIN IMMUNO, 100(1), 2001, pp. 40-48
60. Chen, WR; Thoburn, CJ; Miura, Y; Sommer, M; Hruban, R; Qian, ZP; Baldwin, W; Hess, AD
    Autoimmune-mediated vasculopathy
    CLINICAL IMMUNOLOGY
    
    W.R. Chen et al., "Autoimmune-mediated vasculopathy", CLIN IMMUNO, 100(1), 2001, pp. 57-70
61. Norda, R; Stegmayr, BG
    Apheresis registry in Sweden: scope, techniques and indications for treatment. A report from the Swedish apheresis study group
    TRANSFUSION AND APHERESIS SCIENCE
    
    R. Norda e B.G. Stegmayr, "Apheresis registry in Sweden: scope, techniques and indications for treatment. A report from the Swedish apheresis study group", TRANSF AP S, 24(1), 2001, pp. 49-55
62. Green, RHA; Watson, D; Buchanan, S; Morrison, AE
    A prospective randomised concurrent comparison of the COBE Spectra Version4.7, COBE Spectra Version 6 (auto PBSC (TM)) and Haemonetics MCS plus cellseparators for leucapheresis in patients with haematological and non-haematological malignancies
    TRANSFUSION AND APHERESIS SCIENCE
    
    R.H.A. Green et al., "A prospective randomised concurrent comparison of the COBE Spectra Version4.7, COBE Spectra Version 6 (auto PBSC (TM)) and Haemonetics MCS plus cellseparators for leucapheresis in patients with haematological and non-haematological malignancies", TRANSF AP S, 24(1), 2001, pp. 85-90
63. Rufer, N; Helg, C; Chapuis, B; Roosnek, E
    Human memory T cells: lessons from stem cell transplantation
    TRENDS IN IMMUNOLOGY
    
    N. Rufer et al., "Human memory T cells: lessons from stem cell transplantation", TRENDS IMMU, 22(3), 2001, pp. 136-141
64. Imami, N; Hardy, G; Gotch, F
    Development of immunotherapeutic strategies for HIV-1
    EXPERT OPINION ON BIOLOGICAL THERAPY
    
    N. Imami et al., "Development of immunotherapeutic strategies for HIV-1", EXPERT OP B, 1(5), 2001, pp. 803-816
65. Novelli, EM; Barranger, JA
    Gene therapy for lysosomal storage disorders
    EXPERT OPINION ON BIOLOGICAL THERAPY
    
    E.M. Novelli e J.A. Barranger, "Gene therapy for lysosomal storage disorders", EXPERT OP B, 1(5), 2001, pp. 857-867
66. Sievers, EL
    Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukaemia in first relapse
    EXPERT OPINION ON BIOLOGICAL THERAPY
    
    E.L. Sievers, "Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukaemia in first relapse", EXPERT OP B, 1(5), 2001, pp. 893-901
67. Rousseau, RF; Bollard, CM; Heslop, HE
    Gene therapy for paediatric leukaemia
    EXPERT OPINION ON BIOLOGICAL THERAPY
    
    R.F. Rousseau et al., "Gene therapy for paediatric leukaemia", EXPERT OP B, 1(4), 2001, pp. 663-674
68. Jones, D
    In utero stem cell transplantation: two steps forward but one step back?
    EXPERT OPINION ON BIOLOGICAL THERAPY
    
    D. Jones, "In utero stem cell transplantation: two steps forward but one step back?", EXPERT OP B, 1(2), 2001, pp. 205-212
69. Bhatia, V; Porter, DL
    Novel approaches to allogeneic stem cell therapy
    EXPERT OPINION ON BIOLOGICAL THERAPY
    
    V. Bhatia e D.L. Porter, "Novel approaches to allogeneic stem cell therapy", EXPERT OP B, 1(1), 2001, pp. 3-15
70. Stark, G; O'Brien, SG
    An update on chronic myeloid leukaemia
    CLINICAL MEDICINE
    
    G. Stark e S.G. O'Brien, "An update on chronic myeloid leukaemia", CLIN MED, 1(5), 2001, pp. 354-357
71. Milligan, DW
    The diagnosis and management of acute myeloid leukaemia
    CLINICAL MEDICINE
    
    D.W. Milligan, "The diagnosis and management of acute myeloid leukaemia", CLIN MED, 1(5), 2001, pp. 358-361
72. Samson, D; Singer, CRJ
    Multiple myeloma
    CLINICAL MEDICINE
    
    D. Samson e C.R.J. Singer, "Multiple myeloma", CLIN MED, 1(5), 2001, pp. 365-370
73. Stanworth, SJ; Newland, AC
    Stem cells: progress in research and edging towards the clinical setting
    CLINICAL MEDICINE
    
    S.J. Stanworth e A.C. Newland, "Stem cells: progress in research and edging towards the clinical setting", CLIN MED, 1(5), 2001, pp. 378-382
74. Li, R; Hartley, L; Robb, L
    Cloning of rat interleukin 11 and interleukin 11 receptor alpha chain and analysis of their expression in rat uterus in the peri-implantation period
    REPRODUCTION
    
    R. Li et al., "Cloning of rat interleukin 11 and interleukin 11 receptor alpha chain and analysis of their expression in rat uterus in the peri-implantation period", REPRODUCT, 122(4), 2001, pp. 593-600
75. Dietz, AB; Litzow, MR; Bulur, PA; Vuk-Pavlovic, S
    Transgenic interleukin 2 secreted by CML dendritic cells stimulates autologous T(H)1 T cells
    CYTOTHERAPY
    
    A.B. Dietz et al., "Transgenic interleukin 2 secreted by CML dendritic cells stimulates autologous T(H)1 T cells", CYTOTHERAPY, 3(2), 2001, pp. 97-105
76. Perutelli, P; Murugesan, S; Dini, G
    Adhesion of MNC to extracellular matrix proteins following in vitro photochemotherapy
    CYTOTHERAPY
    
    P. Perutelli et al., "Adhesion of MNC to extracellular matrix proteins following in vitro photochemotherapy", CYTOTHERAPY, 3(1), 2001, pp. 31-36
77. Wedderburn, LR; Jeffery, R; White, H; Patel, A; Varsani, H; Linch, D; Murray, K; Woo, P
    Autologous stem cell transplantation for paediatric-onset polyarteritis nodosa: changes in autoimmune phenotype in the context of reduced diversity of the T- and B-cell repertoires, and evidence for reversion from the CD45RO(+) to RA(+) phenotype
    RHEUMATOLOGY
    
    L.R. Wedderburn et al., "Autologous stem cell transplantation for paediatric-onset polyarteritis nodosa: changes in autoimmune phenotype in the context of reduced diversity of the T- and B-cell repertoires, and evidence for reversion from the CD45RO(+) to RA(+) phenotype", RHEUMATOLOG, 40(11), 2001, pp. 1299-1307
78. Mollee, P; Woodward, N; Durrant, S; Lockwood, L; Gillett, EA; Morton, J; Rowell, J
    Single institution outcomes of treatment of severe aplastic anaemia
    INTERNAL MEDICINE JOURNAL
    
    P. Mollee et al., "Single institution outcomes of treatment of severe aplastic anaemia", INTERN M J, 31(6), 2001, pp. 337-342
79. Dowling, AJ; Prince, HM; Wirth, A; Wolf, M; Januszewicz, EH; Juneja, S; Seymour, JF; Gates, P; Smith, JG
    High-dose therapy and autologous transplantation for lymphoma: The Peter MacCallum Cancer Institute experience
    INTERNAL MEDICINE JOURNAL
    
    A.J. Dowling et al., "High-dose therapy and autologous transplantation for lymphoma: The Peter MacCallum Cancer Institute experience", INTERN M J, 31(5), 2001, pp. 279-289
80. Bylsma, GW; Hall, AJH; Szer, J; West, R
    Atypical retinal microvasculopathy after bone marrow transplantation
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
    
    G.W. Bylsma et al., "Atypical retinal microvasculopathy after bone marrow transplantation", CLIN EXP OP, 29(4), 2001, pp. 225-229
81. Schanz, U
    Allogeneic haematopoietic stem cell transplantation with reduced intensityconditioning regimens ("minitransplants")
    SWISS MEDICAL WEEKLY
    
    U. Schanz, "Allogeneic haematopoietic stem cell transplantation with reduced intensityconditioning regimens ("minitransplants")", SWISS MED W, 131(5-6), 2001, pp. 59-64
82. Kiefel, V
    Platelet antibodies and diagnosis of immune-mediated thrombocytopenia
    INFUSION THERAPY AND TRANSFUSION MEDICINE-INFUSIONSTHERAPIE UND TRANSFUSIONSMEDIZIN
    
    V. Kiefel, "Platelet antibodies and diagnosis of immune-mediated thrombocytopenia", INFUS THER, 28(4), 2001, pp. 209-217
83. Surbek, DV; Schatt, S; Holzgreve, W
    Stem cell transplantation and gene therapy in utero
    INFUSION THERAPY AND TRANSFUSION MEDICINE-INFUSIONSTHERAPIE UND TRANSFUSIONSMEDIZIN
    
    D.V. Surbek et al., "Stem cell transplantation and gene therapy in utero", INFUS THER, 28(3), 2001, pp. 150-158
84. Schlenke, P; Weber, K; Kirchner, H; Wagner, T
    Mafosfamide-purged peripheral blood stem cell harvest: Case report of a 54-year-old patient with relapsed acute myeloid leukemia
    INFUSION THERAPY AND TRANSFUSION MEDICINE-INFUSIONSTHERAPIE UND TRANSFUSIONSMEDIZIN
    
    P. Schlenke et al., "Mafosfamide-purged peripheral blood stem cell harvest: Case report of a 54-year-old patient with relapsed acute myeloid leukemia", INFUS THER, 28(3), 2001, pp. 161-164
85. Seitz, R
    Human cytomegalovirus
    INFUSION THERAPY AND TRANSFUSION MEDICINE-INFUSIONSTHERAPIE UND TRANSFUSIONSMEDIZIN
    
    R. Seitz, "Human cytomegalovirus", INFUS THER, 28(3), 2001, pp. 165-171
86. Trummer, A; Hertenstein, B; Lichtinghagen, R; Ganser, A; Arseniev, L
    Evaluation of a device for negative selection of CD34+cells alone or in combination with breast cancer tumor cell purging
    INFUSION THERAPY AND TRANSFUSION MEDICINE-INFUSIONSTHERAPIE UND TRANSFUSIONSMEDIZIN
    
    A. Trummer et al., "Evaluation of a device for negative selection of CD34+cells alone or in combination with breast cancer tumor cell purging", INFUS THER, 28(2), 2001, pp. 67-72
87. Hromadnikova, I; Sedlacek, P; Stary, J; Cermakova, M; Vavrinec, J; Stechova, K; Dolezalova, L; Sviland, L; Dickinson, AM
    An in vitro skin explant assay as a predictive assay for graft-versus-hostdisease in a cohort of pediatric transplants
    PEDIATRIC TRANSPLANTATION
    
    I. Hromadnikova et al., "An in vitro skin explant assay as a predictive assay for graft-versus-hostdisease in a cohort of pediatric transplants", PEDIAT TRAN, 5(4), 2001, pp. 258-265
88. Remberger, M; Mattsson, J; Ringden, O
    Polyclonal anti-T-cell globulin as part of the preparative regimen for pediatric allogeneic stem-cell transplantation
    PEDIATRIC TRANSPLANTATION
    
    M. Remberger et al., "Polyclonal anti-T-cell globulin as part of the preparative regimen for pediatric allogeneic stem-cell transplantation", PEDIAT TRAN, 5(4), 2001, pp. 285-292
89. Paci, A; Rieutord, A; Brion, F; Prognon, P
    Separation methods for alkylating antineoplastic compounds
    JOURNAL OF CHROMATOGRAPHY B
    
    A. Paci et al., "Separation methods for alkylating antineoplastic compounds", J CHROMAT B, 764(1-2), 2001, pp. 255-287
90. Quernin, MH; Duval, M; Litalien, C; Vilmer, E; Aigrain, EJ
    Quantification of busulfan in plasma by liquid chromatography-ion spray mass spectrometry - Application to pharmacokinetic studies in children
    JOURNAL OF CHROMATOGRAPHY B
    
    M.H. Quernin et al., "Quantification of busulfan in plasma by liquid chromatography-ion spray mass spectrometry - Application to pharmacokinetic studies in children", J CHROMAT B, 763(1-2), 2001, pp. 61-69
91. Priftakis, P; Bogdanovic, G; Kalantari, M; Dalianis, T
    Overrepresentation of point mutations in the Sp1 site of the non-coding control region of BK virus in bone marrow transplanted patients with haemorrhagic cystitis
    JOURNAL OF CLINICAL VIROLOGY
    
    P. Priftakis et al., "Overrepresentation of point mutations in the Sp1 site of the non-coding control region of BK virus in bone marrow transplanted patients with haemorrhagic cystitis", J CLIN VIRO, 21(1), 2001, pp. 1-7
92. Halwachs-Baumann, G; Wilders-Truschnig, M; Enzinger, G; Eibl, M; Linkesch, W; Dornbusch, HJ; Santner, BI; Marth, E; Kessler, HH
    Cytomegalovirus diagnosis in renal and bone marrow transplant recipients: the impact of molecular assays
    JOURNAL OF CLINICAL VIROLOGY
    
    G. Halwachs-Baumann et al., "Cytomegalovirus diagnosis in renal and bone marrow transplant recipients: the impact of molecular assays", J CLIN VIRO, 20(1-2), 2001, pp. 49-57
93. Preiser, W; Brauninger, S; Schwerdtfeger, R; Ayliffe, U; Garson, JA; Brink, NS; Franck, S; Doerr, HW; Rabenau, HF
    Evaluation of diagnostic methods for the detection of cytomegalovirus in recipients of allogeneic stem cell transplants
    JOURNAL OF CLINICAL VIROLOGY
    
    W. Preiser et al., "Evaluation of diagnostic methods for the detection of cytomegalovirus in recipients of allogeneic stem cell transplants", J CLIN VIRO, 20(1-2), 2001, pp. 59-70
94. Kitamura, Y; Hirota, S; Nishida, T
    A loss-of-function mutation of c-kit results in depletion of mast cells and interstitial cells of Cajal, while its gain-of-function mutation results in their oncogenesis
    MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
    
    Y. Kitamura et al., "A loss-of-function mutation of c-kit results in depletion of mast cells and interstitial cells of Cajal, while its gain-of-function mutation results in their oncogenesis", MUT RES-F M, 477(1-2), 2001, pp. 165-171
95. Gorczynski, RM
    Role of cytokines in allograft rejection
    CURRENT PHARMACEUTICAL DESIGN
    
    R.M. Gorczynski, "Role of cytokines in allograft rejection", CUR PHARM D, 7(11), 2001, pp. 1039-1057
96. Bellm, LA; Epstein, JB; Rose-Ped, AM; Fu, R; Martin, PJ; Fuchs, HJ
    Assessment of various topical oral formulations by bone marrow transplant recipients
    ORAL ONCOLOGY
    
    L.A. Bellm et al., "Assessment of various topical oral formulations by bone marrow transplant recipients", ORAL ONCOL, 37(1), 2001, pp. 42-49
97. Inwald, D; Davies, EG; Klein, N
    Demystified ... Adhesion molecule deficiencies
    JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY
    
    D. Inwald et al., "Demystified ... Adhesion molecule deficiencies", J CL PATH-M, 54(1), 2001, pp. 1-7
98. Pangalis, GA; Dimopoulou, MN; Angelopoulou, MK; Tsekouras, C; Vassilakopoulos, TP; Vaiopoulos, G; Siakantaris, MP
    Campath-1H (anti-CD52) monoclonal antibody therapy in lymphoproliferative disorders - A review
    MEDICAL ONCOLOGY
    
    G.A. Pangalis et al., "Campath-1H (anti-CD52) monoclonal antibody therapy in lymphoproliferative disorders - A review", MED ONCOL, 18(2), 2001, pp. 99-107
99. Oktay, K
    Ovarian tissue cryopreservation and transplantation: preliminary findings and implications for cancer patients
    HUMAN REPRODUCTION UPDATE
    
    K. Oktay, "Ovarian tissue cryopreservation and transplantation: preliminary findings and implications for cancer patients", HUM REP UPD, 7(6), 2001, pp. 526-534
100. Meirow, D; Nugent, D
     The effects of radiotherapy and chemotherapy on female reproduction
     HUMAN REPRODUCTION UPDATE
     
     D. Meirow e D. Nugent, "The effects of radiotherapy and chemotherapy on female reproduction", HUM REP UPD, 7(6), 2001, pp. 535-543